stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) Shares outstanding
Oscar Health, Inc.'s shares outstanding at the end of fiscal 2025 was $262.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $346.5M. Over the past ten years it has ranged from $28.8M (fiscal 2019) to $265.9M (fiscal 2024); the current reading is higher than 86% of that period. Oscar Health, Inc. ranks 5th of 12 Healthcare Plans companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $262.4M | (1.30%) |
| FY2024 | $265.9M | 19.94% |
| FY2023 | $221.7M | 4.32% |
| FY2022 | $212.5M | 18.72% |
| FY2021 | $179.0M | 511.58% |
| FY2020 | $29.3M | 1.56% |
| FY2019 | $28.8M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $346.5M | 3.91% |
| Jun 2026 | $333.4M | 1.12% |
| Mar 2026 | $329.8M | 25.67% |
| Dec 2025 | $262.4M | 1.20% |
| 23 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CLOV Clover Health Investments, Corp. compare | $557.5M |
| CNC Centene Corporation compare | $494.1M |
| OSCR Oscar Health, Inc. | $346.5M |
| CI Cigna Group compare | $263.8M |
| ELV Elevance Health, Inc. compare | $217.6M |
| ALHC Alignment Healthcare, Inc. compare | $208.6M |
| HUM Humana Inc. compare | $121.8M |
| PGNY Progyny, Inc. compare | $81.2M |
| MOH Molina Healthcare, Inc compare | $51.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on OSCR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement